stars 1 stars 2 stars 3

iPierian is a biotechnology company targeting secreted Tau for treatment of Alzheimer’s disease and other Tauopathies. The company’s lead drug candidate (IPN007) is a monoclonal antibody targeting a novel form of secreted Tau that is differentially regulated in Alzheimer’s disease patients, designed to slow the spread of Tau throughout the brain and therefore inhibit the associated disease progression.

iPierian Questions

The iPierian annual revenue was $11.8 million in 2026.

1 people are employed at iPierian.

iPierian is based in South San Francisco, California.

The NAICS codes for iPierian are [32, 325, 3254].

The SIC codes for iPierian are [28, 283].

Top iPierian Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users